Search Results - "Sebayang, Boni F"

The Plasmodium falciparum transcriptome in severe malaria reveals altered expression of genes involved in important processes including surface antigen-encoding var genes by Tonkin-Hill, Gerry Q, Trianty, Leily, Noviyanti, Rintis, Nguyen, Hanh H T, Sebayang, Boni F, Lampah, Daniel A, Marfurt, Jutta, Cobbold, Simon A, Rambhatla, Janavi S, McConville, Malcolm J, Rogerson, Stephen J, Brown, Graham V, Day, Karen P, Price, Ric N, Anstey, Nicholas M, Papenfuss, Anthony T, Duffy, Michael F

“…Within the human host, the malaria parasite Plasmodium falciparum is exposed to multiple selection pressures. The host environment changes dramatically in…”
Get full text

Identifying Targets of Protective Antibodies against Severe Malaria in Papua, Indonesia, Using Locally Expressed Domains of Plasmodium falciparum Erythrocyte Membrane Protein 1 by Rambhatla, Janavi S, Tonkin-Hill, Gerry Q, Takashima, Eizo, Tsuboi, Takafumi, Noviyanti, Rintis, Trianty, Leily, Sebayang, Boni F, Lampah, Daniel A, Marfurt, Jutta, Price, Ric N, Anstey, Nicholas M, Papenfuss, Anthony T, Damelang, Timon, Chung, Amy W, Duffy, Michael F, Rogerson, Stephen J

“…Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), a diverse family of multidomain proteins expressed on the surface of malaria-infected…”
Get full text

Australian mosquito assemblages vary between ground and sub-canopy habitats by Sebayang, Boni F, Russell, Tanya L, Staunton, Kyran M, Townsend, Michael, Paton, Christopher, Lehmann, Tovi, Burkot, Thomas R

“…The surveillance and control of mosquito-borne diseases is dependent upon understanding the bionomics and distribution of the vectors. Most studies of mosquito…”
Get full text

Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia by Marfurt, Jutta, Wirjanata, Grennady, Prayoga, Pak, Chalfein, Ferryanto, Leonardo, Leo, Sebayang, Boni F., Apriyanti, Dwi, Sihombing, Maic A.E.M., Trianty, Leily, Suwanarusk, Rossarin, Brockman, Alan, Piera, Kim A., Luo, Irene, Rumaseb, Angela, MacHunter, Barbara, Auburn, Sarah, Anstey, Nicholas M., Kenangalem, Enny, Noviyanti, Rintis, Russell, Bruce, Poespoprodjo, Jeanne R., Price, Ric N.

“…Drug resistant Plasmodium parasites are a major threat to malaria control and elimination. After reports of high levels of multidrug resistant P. falciparum…”
Get full text

Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum by Vaidya, Akhil B., Morrisey, Joanne M., Zhang, Zhongsheng, Das, Sudipta, Daly, Thomas M., Otto, Thomas D., Spillman, Natalie J., Wyvratt, Matthew, Siegl, Peter, Marfurt, Jutta, Wirjanata, Grennady, Sebayang, Boni F., Price, Ric N., Chatterjee, Arnab, Nagle, Advait, Stasiak, Marcin, Charman, Susan A., Angulo-Barturen, Iñigo, Ferrer, Santiago, Belén Jiménez-Díaz, María, Martínez, María Santos, Gamo, Francisco Javier, Avery, Vicky M., Ruecker, Andrea, Delves, Michael, Kirk, Kiaran, Berriman, Matthew, Kortagere, Sandhya, Burrows, Jeremy, Fan, Erkang, Bergman, Lawrence W.

“…The quest for new antimalarial drugs, especially those with novel modes of action, is essential in the face of emerging drug-resistant parasites. Here we…”
Get full text

Potent Ex Vivo Activity of Naphthoquine and Methylene Blue against Drug-Resistant Clinical Isolates of Plasmodium falciparum and Plasmodium vivax by Wirjanata, Grennady, Sebayang, Boni F, Chalfein, Ferryanto, Prayoga, Handayuni, Irene, Trianty, Leily, Kenangalem, Enny, Noviyanti, Rintis, Campo, Brice, Poespoprodjo, Jeanne Rini, Möhrle, Jörg J, Price, Ric N, Marfurt, Jutta

“…The 4-aminoquinoline naphthoquine (NQ) and the thiazine dye methylene blue (MB) have potent in vitro efficacies against Plasmodium falciparum, but…”
Get full text

Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates by Wirjanata, Grennady, Sebayang, Boni F, Chalfein, Ferryanto, Prayoga, Handayuni, Irene, Noviyanti, Rintis, Kenangalem, Enny, Poespoprodjo, Jeanne Rini, Burgess, Steven J, Peyton, David H, Price, Ric N, Marfurt, Jutta

“…Chloroquine (CQ) has been the mainstay of malaria treatment for more than 60 years. However, the emergence and spread of CQ resistance now restrict its use to…”
Get full text

Quantification of Plasmodium ex vivo drug susceptibility by flow cytometry by Wirjanata, Grennady, Handayuni, Irene, Prayoga, Pak, Apriyanti, Dwi, Chalfein, Ferryanto, Sebayang, Boni F, Kho, Steven, Noviyanti, Rintis, Kenangalem, Enny, Campo, Brice, Poespoprodjo, Jeanne Rini, Price, Ric N, Marfurt, Jutta

“…The emergence and spread of multidrug-resistant Plasmodium falciparum and Plasmodium vivax highlights the need for objective measures of ex vivo drug…”
Get full text

Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria by Duffy, Michael F, Noviyanti, Rintis, Tsuboi, Takafumi, Feng, Zhi-Ping, Trianty, Leily, Sebayang, Boni F, Takashima, Eizo, Sumardy, Fransisca, Lampah, Daniel A, Turner, Louise, Lavstsen, Thomas, Fowkes, Freya J I, Siba, Peter, Rogerson, Stephen J, Theander, Thor G, Marfurt, Jutta, Price, Ric N, Anstey, Nicholas M, Brown, Graham V, Papenfuss, Anthony T

“…Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) variants are encoded by var genes and mediate pathogenic cytoadhesion and antigenic variation in…”
Get full text

Quinolone-3-diarylethers: a new class of antimalarial drug by Nilsen, Aaron, LaCrue, Alexis N, White, Karen L, Forquer, Isaac P, Cross, Richard M, Marfurt, Jutta, Mather, Michael W, Delves, Michael J, Shackleford, David M, Saenz, Fabian E, Morrisey, Joanne M, Steuten, Jessica, Mutka, Tina, Li, Yuexin, Wirjanata, Grennady, Ryan, Eileen, Duffy, Sandra, Kelly, Jane Xu, Sebayang, Boni F, Zeeman, Anne-Marie, Noviyanti, Rintis, Sinden, Robert E, Kocken, Clemens H M, Price, Ric N, Avery, Vicky M, Angulo-Barturen, Iñigo, Jiménez-Díaz, María Belén, Ferrer, Santiago, Herreros, Esperanza, Sanz, Laura M, Gamo, Francisco-Javier, Bathurst, Ian, Burrows, Jeremy N, Siegl, Peter, Guy, R Kiplin, Winter, Rolf W, Vaidya, Akhil B, Charman, Susan A, Kyle, Dennis E, Manetsch, Roman, Riscoe, Michael K

“…The goal for developing new antimalarial drugs is to find a molecule that can target multiple stages of the parasite's life cycle, thus impacting prevention,…”
Get more information